2 unknown, 1 recruiting. 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Conventional dose: new trials by email Literature Review of Conventional dose trials Research Report on Conventional dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma Reduced dose, Conventional dose, Chemotherapy - Nasopharyngeal Carcinoma | Phase 2 | Recruiting | Taizhou Hospital | 93 | 2022-01-01 | 2023-02-21 |
| Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery Conventional dose, Dosing according residual heparin - Anticoagulant Antagonist Toxicity | Phase 4 | Unknown | Fundación Clínica Shaio | 136 | 2020-11-15 | 2020-12-01 |
| Intensive Versus Conventional Digoxin Use in Patients With Heart Failure Digoxin dose-adjusted, Standard dose - Heart Failure | Phase 2 / Phase 3 | Unknown | Hospital Ana Nery | 200 | 2016-05-01 | 2016-06-13 |
Heart Failure (1) · Nasopharyngeal Carcinoma (1)
Fundación Clínica Shaio (1) · Hospital Ana Nery (1) · Taizhou Hospital (1)
Brazil (1) · China (1) · Colombia (1)
David Ramez (1) · Haihua Yang, MD (1) · Mauricio Abello (1)